Compare Hims and Hers Health Inc (HIMS) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Twilio Inc — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Twilio Inc trades at $289.47 (market cap $42.35B). The key difference: Twilio Inc is far larger — about 6.5× Hims and Hers Health Inc's market cap, and Twilio Inc is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Twilio Inc for 56 Days on average.
| HIMS | TWLO | |
|---|---|---|
Market Cap | $6.55B | $42.35B |
Volume | 14,842,814 | 1,862,642 |
Sector | Health | Technology |
52-Week High | $62.76 | $301.27 |
52-Week Low | $14.52 | $106.23 |
Typical Hold Time | 21 Days | 56 Days |
Enterprise Value | $7.25B | $40.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.
The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.
Twilio (TWLO) trades at $275.77, up 1.01% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company has shown strong revenue growth, reaching $5.07B in 2025, and a significant improvement in net income to $33.83M. Recent news highlights its upcoming inclusion in the S&P 500 index, reflecting increased market recognition and institutional interest.
Outlook is positive with accelerating revenue growth and profitability, supported by AI-driven communication services. Key risks include high valuation multiples and competitive pressures. Analyst consensus is bullish with a 76.92% buy rating, though price targets suggest near-term consolidation potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
